Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-masked, Placebo-controlled, Multicenter Study of the Efficacy and Safety of Phentolamine Ophthalmic Solution (POS) 0.75% in Participants With Presbyopia

NCT06542497 is registered in ClinicalTrials.gov with Ocuphire Pharma, Inc. as lead sponsor.

NCT NCT06542497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06542497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-masked, Placebo-controlled, Multicenter Study of the Efficacy and Safety of Phentolamine Ophthalmic Solution (POS) 0.75% in Participants With Presbyopia
Lead sponsor
Ocuphire Pharma, Inc.
Phase
Phase 3
Overall status
Completed
Start date
August 15, 2024
Completion date
January 22, 2026
Enrollment
569 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

presbyopia